EHRA is establishing grants for drug policy and harm reduction organizations working to address human rights violations during Covid-19 in the CEECA region.
Correlation-EuroHRN hosts a series of seminars on subjects such as COVID-19's effects on harm reduction efforts for people who use drugs, different approaches to decriminalisation, and more ethical drug policies.
Jamie Bridge from the International Drug Policy Consortium (IDPC) will overview the international drug control system, the relevant UN agencies and discuss what comes next
EHRN's Regional Program is aimed at reducing the spread of the HIV epidemic in Eastern Europe and Central Asia through intensified efforts to advocate for harm reduction.
The Regional Harm Reduction Conference will be dedicated to the results, lessons learnt, and perspectives of civil society and community-driven advocacy for sustainable and high-quality harm reduction programs in CEECA.
EHRN and the European Commission launched a project to work on drug policy evaluation mechanisms and promote transparent and evidence-based decision-making processes.
Iran has managed to build its own harm reduction system, sustainable in its own way. It is not like any other western system and not quite like the systems described in manuals and recommended by WHO and UNAIDS.
This four day conference, organised by The Eurasian Harm Reduction Network (EHRN) will serve as a regional discussion platform in advance to the 25th International Harm Reduction Conference in Montreal in 2017, and to the 22th International AIDS Conference in 2018.
This tool offers self-guided education on police violence against women who use drugs. It may also be interesting to other professionals, including social workers, health care professionals, and providers of harm reduction services as an advocacy tool for fairer drug policies.
